Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Bellei

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Haematologica|April 2, 2019
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell ProjectMonica Bellei, Massimo Federico
The Lancet. Oncology|November 2, 2013
BEACOPP or no BEACOPP?Massimo Federico, Monica Bellei, Bruce D Cheson
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Follicular lymphoma - treatment and prognostic factorsStefano Luminari, Monica Bellei, Irene Biasoli, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Prognostic factors in low-grade non-Hodgkin lymphomasMassimo Federico, Stefano Molica, Monica Bellei, et al.
Current Hematologic Malignancy Reports|October 10, 2015
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell ProjectMonica Bellei, Chadi Nabhan, Emanuela Anna Pesce, et al.
Hematological Oncology|April 30, 2014
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer RegistryIrene Biasoli, Marina Cesaretti, Monica Bellei, et al.
Haematologica|November 13, 2008
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term resultsAngelo Michele Carella, Monica Bellei, Pauline Brice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapyMassimo Federico, Monica Bellei, Pauline Brice, et al.
Hematological Oncology|July 27, 2007
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern ItalyStefano Luminari, Marina Cesaretti, Ivan Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study databasePhilippe Solal-Céligny, Monica Bellei, Luigi Marcheselli, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Haematologica|April 2, 2019
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell ProjectMonica Bellei, Massimo Federico
The Lancet. Oncology|November 2, 2013
BEACOPP or no BEACOPP?Massimo Federico, Monica Bellei, Bruce D Cheson
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Follicular lymphoma - treatment and prognostic factorsStefano Luminari, Monica Bellei, Irene Biasoli, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Prognostic factors in low-grade non-Hodgkin lymphomasMassimo Federico, Stefano Molica, Monica Bellei, et al.
Current Hematologic Malignancy Reports|October 10, 2015
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell ProjectMonica Bellei, Chadi Nabhan, Emanuela Anna Pesce, et al.
Hematological Oncology|April 30, 2014
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer RegistryIrene Biasoli, Marina Cesaretti, Monica Bellei, et al.
Haematologica|November 13, 2008
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term resultsAngelo Michele Carella, Monica Bellei, Pauline Brice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapyMassimo Federico, Monica Bellei, Pauline Brice, et al.
Hematological Oncology|July 27, 2007
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern ItalyStefano Luminari, Marina Cesaretti, Ivan Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study databasePhilippe Solal-Céligny, Monica Bellei, Luigi Marcheselli, et al.
Pageof 4